Gene · 5699
Papers1,534
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1 to 20 of 1,534
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| MLN4924 suppresses kidney renal clear cell carcinoma progression through coordinated inhibition of Cullin1 neddylation and PSMB10-associated NF-κB inflammatory signaling. | Inflamm Res | 2026 | 42802181 | PubTator, text mining | PubMed |
| A Novel Dominantly Segregating PSMB10 Splice-Site Variant in Familial Autoinflammatory Disease with Immunoproteasome and Interferon-Related Dysregulation. | Genes (Basel) | 2026 | 42792891 | PubTator, text mining | PubMed |
| Type I and II Interferon Signalling Characterizes the Transcriptional Landscape of Sweet Syndrome. | Exp Dermatol | 2026 | 42410891 | PubTator, text mining | PubMed |
| From polyamine metabolism genes to immunoproteasome subunits: a transcriptome-based screening of candidate biomarkers in Crohn's disease. | Sci Rep | 2026 | 42401658 | PubTator, text mining | PubMed |
| Pan-cancer analysis identifies immunoproteasome as the predominant survival-associated component of antigen processing machinery. | Transl Oncol | 2026 | 42364494 | PubTator, text mining | PubMed |
| Functional characterization of EcPSMB10: Suppression of RGNNV replication via inhibiting autophagy in vitro. | Fish Shellfish Immunol | 2026 | 42229675 | PubTator, text mining | PubMed |
| Identification of Polyamine Metabolism-Related Biomarkers in Psoriasis: A Study Based on Transcriptomics and Single-Cell Sequencing. | Exp Dermatol | 2026 | 42223029 | PubTator, text mining | PubMed |
| NSCLC brain metastases exhibit reduced HLA-I antigen presentation machinery and immune evasion independent of IFNγ signaling defects. | Mol Cancer | 2026 | 42210261 | PubTator, text mining | PubMed |
| Novel de novo dominant PSMB10 variants in three patients with immune deficiency and liver disease. | J Hum Immun | 2026 | 42170594 | PubTator, text mining | PubMed |
| Monoallelic PSMB8 variants cause PRAAS with immunodeficiency through impaired immunoproteasome assembly. | Am J Hum Genet | 2026 | 42167218 | PubTator, text mining | PubMed |
| Characterization of T-Cell Ubiquitination in Melanoma and Development of a Risk Signature Using Single-Cell and Bulk RNA-Seq. | Immunology | 2026 | 42012139 | PubTator, text mining | PubMed |
| Dominant-negative PSMB10 disrupts immunoproteasome assembly and leads to transient T lymphopenia. | J Hum Immun | 2026 | 41971628 | PubTator, text mining | PubMed |
| Prediction of immune checkpoint inhibitor therapy in urothelial carcinoma: integrated analysis of molecular patterns and clinical factors | Magy Onkol | 2026 | 41819065 | PubTator, text mining | PubMed |
| Protein abundance inference via expectation-maximization in fluorosequencing. | Bioinform Adv | 2026 | 41800381 | PubTator, text mining | PubMed |
| Sarcomatoid Renal Cell Carcinoma: Biological Features and Therapeutic Implications-A Narrative Review. | Curr Urol Rep | 2026 | 41792526 | PubTator, text mining | PubMed |
| Integrating interferon gamma receptor pathways, antigenicity, and immune contexture as predictors of immunotherapeutic strategies for mucosal melanomas. | J Immunother Cancer | 2026 | 41791790 | PubTator, text mining | PubMed |
| SWI/SNF-associated molecular subtypes reshape tumor microenvironmental features and inform precision therapeutic strategies in bladder cancer. | Front Cell Infect Microbiol | 2026 | 41789425 | PubTator, text mining | PubMed |
| Dual targeting of the UPS and autophagy as a novel therapy for neurodegenerative proteinopathies. | Front Cell Neurosci | 2026 | 41788195 | PubTator, text mining | PubMed |
| Genomic landscape, immune microenvironment and survival in male versus female breast cancer. | ESMO Open | 2026 | 41785670 | PubTator, text mining | PubMed |
| Role of E5 from HPV16 in the Evasion of the Immune Response. | Int J Mol Sci | 2026 | 41752120 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5699/papers